Chester S. Zygmont, III
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chester S. Zygmont, III
Chester S. Zygmont, III is recorded as CFO at Revelation Biosciences, Inc. (REVB). Revelation Biosciences, Inc. reported in an 8-K filed June 24, 2026 that Chester S. Zygmont, III was appointed Chief Financial Officer, effective June 24, 2026.
“WHEREAS, the Company wishes to continue to employ, and Executive wishes to continue employment with the Company, as the Chief Financial Officer of the Company, pursuant to the terms and conditions set forth in this Agreement, effective as of June 24, 2026 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Revelation Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- James Rolke CEO, Board Member
- Chester S. Zygmont CFO
- Anthony Hayes Board Member
- George F. Tidmarsh Board Member
- Jennifer Carver Board Member
- Jess Roper Board Member
- Lakhmir Chawla Board Member
- Lakhmir Chawla M.D. Board Member
- William H. Carson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.